Results
1 -
9 of
9
(Click
here to explore results)
- Small molecules targeting phosphoinositide 3-kinases. Peng Wu, Yongzhou Hu
, Med. Chem. Commun.
, 2012
, 3
, 1337
- Inhibitors of phosphoinositide-3-kinase: a structure-based approach to understanding potency and selectivity. Teather J. Sundstrom, Amy C. Anderson, Dennis L. Wright
, Org. Biomol. Chem.
, 2009
, 7
, 840
- Target identification of small molecules based on chemical biology approaches. Yushi Futamura, Makoto Muroi, Hiroyuki Osada
, Mol. BioSyst.
, 2013
, 9
, 897
- Recent biological applications of heterocyclic hybrids containing s-triazine scaffold. Muhammad Imran Ali, Muhammad Moazzam Naseer
, RSC Adv.
, 2023
, 13
, 30462
- Recent developments in anticancer kinase inhibitors based on the pyrazolo[3,4-d]pyrimidine scaffold. Daniel J. Baillache, Asier Unciti-Broceta
, RSC Med. Chem.
, 2020
, 11
, 1112
- Metal-free 18F-labeling of aryl-CF2H via nucleophilic radiofluorination and oxidative C–H activation. Gengyang Yuan, Feng Wang, Nickeisha A. Stephenson, Lu Wang, Benjamin H. Rotstein, Neil Vasdev, Pingping Tang, Steven H. Liang
, Chem. Commun.
, 2017
, 53
, 126
- Elaborating piperazinyl-furopyrimidine based scaffolds as phosphoinositol-3-kinase enzyme alpha (PI3Kα) inhibitors to combat pancreatic cancer. Mai A. Mansour, Deena S. Lasheen, Hatem M. Gaber, Khaled A. M. Abouzid
, RSC Adv.
, 2020
, 10
, 32103
- PI3K inhibitors: review and new strategies. Mingzhen Zhang, Hyunbum Jang, Ruth Nussinov
, Chem. Sci.
, 2020
, 11
, 5855
- Retracted Article: LncRNA ZEB2-AS1 regulates the drug resistance of acute myeloid leukemia via the miR-142-3p/INPP4B axis. Kai Wang, Jing Dai, Tao Liu, Qiong Wang, Yingxu Pang
, RSC Adv.
, 2019
, 9
, 39495